Bird Flu and Bureaucracy: How Political Maneuvering Threatens America’s Pandemic Preparedness
When public health collides with politics, the resulting reverberations can jeopardize entire populations. On a bleak morning this May, dairy ...
A Pact Amidst Power Plays: The WHO’s Pandemic Agreement and the Fragile Balance Between Sovereignty and Solidarity
In a historic moment steeped in symbolism and surrounded by palpable tension, the World Health Organization (WHO) adopted its first-ever ...
Signals and Silos: Telehealth’s Decentralized Revolution and the Fragmentation of Patient Trust
The future of healthcare may no longer be in the clinic—it may be in the connection. In just five years, ...
Bought and Billed: How Healthcare Mergers Are Undermining the Meaning of Care
Hospitals are being bought faster than patients can heal. In 2025, the healthcare industry is in the throes of another ...
Every Step Counts: How Casual Walking Quietly Fights Cancer
No sweat. No spandex. Just steps. That’s the quietly radical message behind a new study from the University of Oxford, ...
Cleared for Breath, Clouded in Doubt: The Political Economy Behind the FDA’s Approval of Nucala for COPD
Hope often comes with a disclaimer. That was the unspoken sentiment last week when the U.S. Food and Drug Administration ...
Digital Dialogues and Human Silences: Can AI Ever Truly Practice Therapy?
The soul, said Emerson, "refuses all methods." And yet, medicine has never stopped trying to methodize the soul. Now, in ...
More Than a Pop Star Problem: Miley Cyrus, Ovarian Cysts, and the Silence Around Gynecological Pain
It wasn’t a red carpet moment, but it made headlines just the same. In a candid interview, pop icon Miley ...
The Loneliness Cure: Why Social Connection May Be Medicine’s Most Underrated Intervention
The most potent threat to your health might not be high cholesterol, diabetes, or smoking—it might be loneliness. In a ...
When Free Speech Hurts: TikTok, Eating Disorders, and the Ethics of the Algorithm
Freedom of speech was not designed to help teenagers starve. Yet on TikTok, it often does. A single swipe can ...
Clot Watch: How AI Is Rewriting the Rules of Cardiovascular Medicine
A clot moves in silence—until it kills. That brutal, biological truth has haunted emergency rooms for decades. Strokes, heart attacks, ...
The Mind on Medication: Untangling GLP-1 Drugs, Mental Health, and the Viral Echo Chamber
What if the biggest side effect of Ozempic isn’t physiological—but psychological? In the swelling wake of Ozempic’s meteoric rise as ...
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read morePopular
-
The IRA’s Drug Negotiation Mechanism Meets the Rebate Industrial Complex
-
Two Platforms, Two Theories of Change in Hospital Pricing
-
The Payer’s Dilemma: Choosing Between Negotiation Intelligence and Market Disclosure
-
Growth Hormone Secretagogues and the Longevity Trade-Off
-
GLP-1 Agonists Beyond Obesity: The Expanding Therapeutic and Optimization Frontier
